Evaluators and researchers who work with market research panels are used to a particular kind of efficiency. You specify your sample criteria, a panel provider delivers respondents, data collection proceeds, and the project moves forward. The panel handles recruitment logistics so the evaluation/research team can focus on the substantive work.
That efficiency, however, creates a quiet structural tension with the National Statement on Ethical Conduct in Human Research 2025. The tension sits specifically around incentive disclosure, a topic that is easy to underestimate until you find yourself in a review meeting where no one has a clear answer.
This resource explains what market research panels are, where the structural mismatch with the National Statement arises, why it is not easily fixed by simply "asking the applicant," and what evaluators and researchers can do to navigate it.
What Is a Market Research Panel?
If you have never worked with a panel provider directly, the concept is straightforward. A market research panel is a database of pre-registered individuals who have agreed to be contacted for research and evaluation participation. They have provided demographic information such as age, gender, location, occupation, household income, and other attributes, so that they can be filtered by the panel provider to supply a targeted sample for a given project.
Panel providers are contracted by market research firms, social research organisations, and sometimes by evaluators and researchers directly to recruit respondents for surveys, interviews, and focus groups. If you have ever encountered an online advertisement asking you to "get paid to complete surveys," you have seen a panel recruitment campaign.
In Australia, any panel provider aiming to be competitive and credible in the market will hold ISO 20252 certification. This is an independently audited standard for market, opinion and social research. It covers a range of operational requirements, including how panels are managed, how sample quality is maintained, and how incentives are administered (Section A.5.6.2 of that standard). Importantly, the standard does not prescribe incentive rates, but it does establish a framework for ensuring that incentive practices are consistent with the integrity of market research panel operations and the ethical engagement of participants. Certification requires ongoing audit by an accredited body, so it is not simply a self-assessment.
The use of panels is common in applied social research, market research, and evaluation contexts. A policy evaluator assessing public awareness of a new program might recruit a nationally representative online sample through a panel. A social researcher exploring community attitudes towards housing affordability might use a panel to target specific demographics in particular postcodes. A market researcher testing consumer response to a proposed product design will almost certainly use one.
What the National Statement Requires
The National Statement 2025 has several relevant touchpoints when evaluators and researchers use participant incentives.
The foundational principle is in paragraphs 2.2.1 and 2.2.2: participation must be voluntary and based on sufficient information and adequate understanding. The voluntariness of participation is not a formality, it is what gives informed consent its ethical weight. This matters directly to incentive arrangements, because payment is a factor that can compromise voluntariness if it is disproportionate to what is being asked or if it creates pressure on individuals to consent.
Paragraph 2.2.6(j) is the specific disclosure requirement: among the information that should be communicated to participants is any payments to participants. This sits alongside other disclosures such as funding sources, researchers' conflicts of interest, and the right to withdraw.
Paragraphs 2.2.10 and 2.2.11 go further, drawing a normative line. Reimbursement of reasonable costs, including compensation for time, is generally appropriate. But payment that is disproportionate to the time involved, or any inducement likely to encourage participants to take risks, is ethically unacceptable. The National Statement also requires that customs and practices of the relevant community be taken into account.
Paragraph 3.1.21 brings these threads together from the perspective of recruitment design. Reviewers and evaluators/researchers should consider the degree to which any payment, whether to participants or to others involved in recruitment, could result in pressure on individuals to consent. This is especially important where research involves more than lower risk.
Together, these provisions paint a consistent picture. Incentives need to be disclosed to participants, they need to be proportionate, and their potential to compromise voluntariness needs to be assessed and managed. The committee needs enough information to make those judgements. The problem is that in a market research panel context, this information is often simply not available to the applicant.
The Structural Problem
When an evaluator or researcher contracts a panel provider to supply respondents, the incentive paid to those respondents is typically determined entirely by the panel provider. It is commercial-in-confidence information. Panel providers do not routinely disclose their incentive rates to the organisations that commission them for understandable commercial reasons.
Incentive structures in the panel industry are not simple. Many providers use dynamic pricing models, adjusting incentive rates based on the difficulty of obtaining sufficient sample (for example, a low-incidence target group or a lengthy survey). Some providers subcontract to other panels when their own panel cannot deliver the required sample, potentially introducing further incentive variation. The rates themselves are guarded because a competitor can reverse-engineer a provider's profit margins from disclosed rates, and (at least in principle) could use that knowledge to attract panel members with higher-value offers.
This means that when an ethics committee asks an applicant "what incentives will be paid to participants?", the applicant genuinely may not know. Not because they have failed to consider the question, but because the information is structurally inaccessible to them under standard contracting arrangements with panel providers.
The applicant can state what they have been told. This is typically something like "participants will receive points redeemable for rewards through the panel provider's rewards scheme" or "participants receive an incentive determined by the panel provider," but they cannot state a dollar figure with confidence because they are not privy to it.
This creates a real problem for committees. The information in paragraph 2.2.6(j), the proportionality assessment in paragraphs 2.2.10-11, and the broader recruitment risk assessment in paragraph 3.1.21 all require understanding of what participants are actually being offered. Without that, a committee is being asked to assess whether incentives are proportionate and whether they risk compromising voluntariness without the primary piece of information needed to make that judgement.
Why This Matters for Beneficence and Respect
The issue is not merely procedural. It speaks directly to two of the four core values of the National Statement.
Beneficence (paragraph 1.6) requires that the likely benefit of the research justifies any risks. The risk in question here is the risk that an incentive payment is disproportionate and encourages people to participate who otherwise would not or who would participate in more research than is in their interests. The panel industry manages this through mechanisms built into the ISO 20252 standard, including controls on how often the same person can participate in studies within a given period. But the committee cannot assume those controls are sufficient without understanding the incentive context in which they operate.
Respect (paragraphs 1.10-1.12) requires genuine voluntary consent. The voluntariness of a participant's decision is not self-evidencing. Where incentives are significant enough to exert undue influence, the voluntariness of consent is compromised. The committee needs information to assess this risk, and the standard panel contracting model does not supply it.
What Evaluators and Researchers Can Do
The National Statement does not create an explicit mechanism to compel applicants to obtain specific incentive information from panel providers. But the absence of that mechanism does not mean evaluators and researchers are without options. There is, in fact, a practical toolkit available. The right choice will depend on the risk profile of the specific project.
Option 1: Specify your own incentive payment.
This is the cleanest solution and removes the structural problem entirely. Rather than leaving incentive determination to the panel provider, the evaluator or researcher specifies the incentive in their contract with the panel provider and pays it directly. Panel providers will generally accommodate this arrangement. The incentive chosen by the researcher will almost always exceed the equivalent panel rate (panel incentives are calibrated to volume and margin, not to what an individual researcher would consider appropriate) but the advantage is full transparency. The applicant knows what participants are being offered, can assess proportionality, can document this in the application, and the committee has what it needs to make an informed decision.
For projects involving higher-risk participant groups or sensitive subject matter, this approach is strongly recommended. It is the most straightforward way to satisfy the requirements of paragraphs 2.2.6(j), 2.2.10, and 3.1.21 in a panel-based context.
Option 2: Confirm ISO 20252 certification and describe the incentive mechanism.
Where specifying the incentive directly is not practical, for example, in standard commercial market research projects where the panel provider's pricing model is part of the commercial arrangement, the next best approach is to confirm the panel's ISO 20252 certification and describe the incentive mechanism as accurately as possible.
ISO 20252 establishes a framework for ensuring that incentive practices are consistent with the ethical engagement of participants, including controls on how frequently the same individual can participate in research within a given period. The standard does not prescribe rates, but certification means those practices have been independently assessed. Applicants can confirm certification (which is publicly verifiable), describe the type of incentive in use (points-based rewards, cash-equivalent vouchers, or direct payment), and explain that the specific rate is commercially confidential and determined by the provider.
Many ISO 20252-certified providers will also confirm in writing, on request, that their incentive practices for a particular study type comply with the standard. Where this confirmation can be obtained, it should be included in the application.
Option 3: Calibrate your approach to the risk profile of the project.
The risk context of a project should determine how much effort is invested in resolving the incentive information gap. Paragraph 3.1.21 is explicit: the risk of incentives compromising voluntariness is especially important for research involving more than lower risk.
For a low-risk, de-identified online survey of the general population, such as the kind of omnibus research common in market research and program evaluation, Option 2 will typically be sufficient. The combination of ISO 20252 certification and a description of the incentive mechanism gives the committee enough context to assess the risk proportionately.
For research involving participants who may be more susceptible to the influence of payment, for example people experiencing financial hardship, specific disadvantaged groups, or participants in sensitive or emotionally taxing studies, Option 1 is the appropriate choice. The evaluator or researcher should specify the incentive, assess its proportionality directly, and document that assessment in the application.
In all cases: be explicit, not vague.
Whatever option is used, the application should address incentives directly rather than leaving the matter unmentioned. A vague statement such as "participants will be compensated through the panel" creates more uncertainty for the committee than a clear explanation of why specific figures are unavailable and what governance framework applies instead. Ethics review bodies are capable of working with honest accounts of structural complexity. They are much less well-served by applications that treat the subject as too awkward to address.
Practical Examples
Example 1: Program evaluation with a general population online survey
A policy consulting firm is conducting an evaluation of a Commonwealth-funded financial literacy initiative. Part of the evaluation involves a nationally representative online survey of 2,000 adults to assess awareness and self-reported behaviour change. The survey is 12 minutes in length and collects no sensitive personal information. A panel provider is contracted to deliver the sample.
The ethics application explains that incentive payment details are held by the panel provider and are commercial-in-confidence, confirms that the provider is ISO 20252 certified, and notes that participants will receive rewards through the provider's standard points programme. The application also notes the survey duration and de-identified nature of the data as context for assessing proportionality.
For a lower-risk project of this nature, this approach is appropriate. The incentive mechanism is described honestly, the ISO 20252 framework provides governance context, and the risk profile does not indicate a need to go further.
Example 2: Social research with a targeted population experiencing financial disadvantage
A university research team is conducting a study on financial hardship and access to emergency services. Participants are specifically recruited to include people on low incomes or receiving government payments. The study involves a 45-minute online survey and an optional follow-up interview.
The research team has correctly identified that the risk of incentive payments disproportionately influencing participation is elevated in this cohort. Participants experiencing financial hardship may have less capacity to decline an offer of payment, which creates a genuine risk to the voluntariness of consent.
In this scenario, the research team should specify the incentive directly in their contract with the panel provider rather than leaving the rate to the provider's discretion. The specified incentive (calculated as reasonable compensation for 45–60 minutes of a participant's time) should be documented in the ethics application, with an explicit proportionality assessment. If the team is uncertain what "reasonable" looks like in this context, that is itself a reason to seek early advice before finalising the contracting arrangements.
Example 3: Commissioned market research on consumer attitudes to a government service
A government department has contracted a market research firm to evaluate consumer attitudes to a proposed new service design. The market research firm subcontracts sampling to a panel provider. The ethics application is lodged by the market research firm.
In this multi-party arrangement, the incentive information is two steps removed from the applicant: department → market research firm → panel provider. The market research firm should address this directly in the application by confirming the panel provider's ISO 20252 certification and confirming that participants are informed of the nature of any incentive by the panel provider prior to deciding whether to participate, which, under normal panel practice and ISO 20252 requirements, they will be.
The market research firm should resist the temptation to simply omit the incentive question from the application because it seems complicated. A brief, accurate account of the contracting structure and the governance framework that applies to participant incentives is far better than silence.
A Note on What Participants Are Told
It is worth being explicit about one aspect that the above discussion can obscure. Paragraph 2.2.6(j) requires that any payments to participants be communicated to participants. In a panel-based study, participants typically are informed of the incentive by the panel provider at the point of recruitment, before they decide whether to participate. This is a core part of how panels operate and is a requirement of the ISO 20252 standard.
So the disclosure to participants is in normal panel practice happening. The problem is not a failure of disclosure to participants. The problem is that the information disclosed to participants by the panel provider is not routed back through the evaluator or researcher to the ethics committee. The committee therefore cannot verify it through the application.
That is a governance gap rather than an ethical failure, but it is a gap worth naming honestly in an application, rather than leaving the committee to wonder whether the matter has been considered at all.
Summary
Market research panels are a well-governed, commonly used participant recruitment mechanism in social research, market research, and evaluation contexts. Their use does not create ethical problems in itself. What it does create is a specific structural information gap: incentive rates paid to panel participants are typically commercial-in-confidence information that evaluators and researchers cannot readily obtain, and therefore cannot disclose to ethics committees in the way the National Statement anticipates.
The practical response is calibrated to project risk. For lower-risk projects, confirming ISO 20252 certification and describing the incentive mechanism clearly in the application will generally be sufficient. For higher-risk projects, particularly those involving participants who may be more susceptible to the influence of payment, evaluators and researchers should specify the incentive directly in the panel contract, assess its proportionality, and document that assessment in the application. This removes the structural problem entirely and gives the committee what it needs.
In all cases, the application should address incentives explicitly. An honest account of the contracting structure and the governance framework that applies is always better than silence.
The broader point is worth stating plainly. The National Statement was developed primarily with medical and clinical research paradigms in mind. The market research and applied social research sectors operate within their own industry governance frameworks that often parallel the National Statement's objectives but through different mechanisms. Understanding those mechanisms, including what ISO 20252 actually governs, and what it does not, helps evaluators and researchers design applications that are both honest and well-calibrated to the risks that actually exist in their projects.
If you are designing an evaluation/research project involving a market research panel and are unsure how to approach the incentive question in your application, get in touch. Early advice is the most efficient way to avoid this becoming a sticking point in the review process.
AI Disclosure: Initial drafts of the content for this article were prepared using Large Language Models with input from Iris Ethics staff who guided the scope and design. Subsequent revisions and final versions were developed and approved by Iris Ethics staff.